We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$7.15B
AUM Growth
+$778M
Cap. Flow
+$799M
Cap. Flow %
11.18%
Top 10 Hldgs %
9.56%
Holding
5,720
New
998
Increased
1,852
Reduced
1,702
Closed
889

Sector Composition

Rank Sector Weight
1 Healthcare 3.37%
2 Technology 1.88%
3 Consumer Discretionary 1.68%
4 Energy 1.47%
5 Financials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
201
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$7.34M 0.1%
250,000
-29,000
-10% -$980K
ARIA
202
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$7.32M 0.1%
885,400
+101,300
+13% +$896K
FTR
203
CALL
DELISTED
Frontier Communications Corp.
FTR
$7.29M 0.1%
98,200
+32,633
+50% +$2.91M
ET icon
204
PUT
Energy Transfer Partners
ET
$69.8B
$7.25M 0.1%
225,800
+117,400
+108% +$3.93M
NFX
205
CALL
DELISTED
Newfield Exploration
NFX
$7.22M 0.1%
200,000
+30,100
+18% +$1.12M
SRPT icon
206
PUT
Sarepta Therapeutics
SRPT
$1.68B
$7.21M 0.1%
237,000
+109,100
+85% +$2.23M
LUMN icon
207
PUT
Lumen
LUMN
$6.65B
$7.2M 0.1%
245,000
+207,300
+550% +$7.06M
HLT icon
208
PUT
Hilton Worldwide
HLT
$70.7B
$7.16M 0.1%
86,567
+69,067
+395% +$6.06M
FTNT icon
209
CALL
Fortinet
FTNT
$120B
$7.1M 0.1%
858,500
+483,500
+129% +$3.75M
SRPT icon
210
Sarepta Therapeutics
SRPT
$1.68B
$7.03M 0.1%
230,996
+96,347
+72% +$1.97M
NOK icon
211
CALL
Nokia
NOK
$52.3B
$7.03M 0.1%
1,025,500
-30,800
-3% -$224K
AGO icon
212
PUT
Assured Guaranty
AGO
$3.72B
$7.01M 0.1%
292,200
+162,200
+125% +$4.52M
DOC icon
213
PUT
Healthpeak Properties
DOC
$14.9B
$6.98M 0.1%
210,267
+195,664
+1,340% +$7.12M
LKM
214
CALL
DELISTED
Link Motion Inc.
LKM
$6.95M 0.1%
1,316,500
+204,700
+18% +$911K
DHR icon
215
PUT
Danaher
DHR
$139B
$6.94M 0.1%
+120,663
New +$6.91M
VOD icon
216
CALL
Vodafone
VOD
$35.9B
$6.88M 0.1%
188,800
-159,700
-46% -$5.75M
CLDX icon
217
Celldex Therapeutics
CLDX
$2.96B
$6.87M 0.1%
18,159
-4,015
-18% -$1.59M
LUMO
218
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$6.86M 0.1%
17,211
+5,378
+45% +$2.29M
CRR
219
CALL
DELISTED
Carbo Ceramics Inc.
CRR
$6.84M 0.1%
164,400
+35,900
+28% +$1.45M
VTLE
220
CALL
DELISTED
Vital Energy
VTLE
$6.77M 0.09%
26,910
+17,060
+173% +$4.87M
ENDP
221
PUT
DELISTED
Endo International plc
ENDP
$6.76M 0.09%
84,900
+24,700
+41% +$2.13M
GLNG icon
222
Golar LNG
GLNG
$5B
$6.74M 0.09%
144,075
-39,369
-21% -$1.71M
AVGO icon
223
PUT
Broadcom
AVGO
$1.87T
$6.74M 0.09%
+507,000
New +$6.64M
FMSA
224
CALL
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$6.74M 0.09%
823,000
+608,000
+283% +$5.22M
HALO icon
225
PUT
Halozyme
HALO
$9.76B
$6.47M 0.09%
286,600
+161,100
+128% +$2.83M

Similar funds

Group One Trading's Q2 2015 Portfolio in Review

As of Q2 2015, Group One Trading held 5,720 positions worth $7.15B, up 12% from $6.37B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Group One Trading deployed $799M of net new capital in Q2 2015, opening 998 new positions and adding to 1,852 existing holdings. Its largest new stake was Viatris: 122,934 shares worth $8.34M.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, up from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Allergan plc, an estimated $21.2M trimmed.

  • Group One Trading's largest Q2 2015 buy was Viatris: 122,934 shares worth $8.34M.
  • Group One Trading added most to Williams Companies in Q2 2015, an estimated $22.3M increase.
  • Group One Trading's biggest Q2 2015 reduction was Allergan plc, cutting an estimated $21.2M.
  • Group One Trading fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $89.2M.
  • Group One Trading's ten largest holdings make up 9.6% of its $7.15B portfolio in Q2 2015.
  • Group One Trading opened 998 new positions and closed 889 in Q2 2015.
  • Group One Trading's portfolio value rose 12% quarter-over-quarter to $7.15B.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.